The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

XFOR FINANCIAL STATEMENTS

X4 Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

XFORX4 Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-100 M-50 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue15.8 M $Gross Profit12.9 M $ · 81%Operating Income-87.9 M $ · -555%Pre-tax Income-90.2 M $ · -569%Net Income to Owners-90.1 M $ · -569%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue15.8 M $-51.6%
Gross Profit12.9 M $-51.7%
Operating Income-87.9 M $—
EBITDA-79.5 M $—
Net Income to Owners-90.1 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0100 M200 M300 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets253.1 M
  • Equity155.5 M $61%
  • Current Liabilities19.4 M $8%
  • Long-term Liabilities78.2 M $31%

Key Figures

YoY change
Total Assets253.1 M $+140.6%
Total Liabilities97.6 M $-3.5%
Total Equity155.5 M $+3,814.7%
Cash & ST Investments208 M $+230.4%
Total Debt465 K $-99.4%
Net Debt-194.6 M $-601.6%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M-50 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M0100 M-103.3 M $Operating25.7 M $Investing233.1 M $Financing155.4 M $Net Change

Key Figures

YoY change
Operating Cash Flow-103.3 M $—
Capital Expenditures25.6 M $+717.1%
Free Cash Flow-103.3 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on XFOR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.